Amesite Inc. (AMST) stock
Close on Nov 13, 2026Market cap $3.11MP/E –Yield –
Amesite Inc. grew revenue 76.1% to $340.70K over the twelve months to Sep 30, 2026. Free cash flow was -$2.15M. At the latest close the market valued the company at $3.11M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $3.11M
- P/E ratio
- –
- Price to sales
- 9.13
- Price to book
- 1.58
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $340.70K
- Net income
- -$3.23M
- EPS, diluted
- -$0.60
- Free cash flow
- -$2.15M
- Book value per share
- $0.30
- Diluted shares
- 7M
Trading
- Previous close
- $0.48
- Open
- $0.47
- Day's range
- $0.47 – $0.53
- Volume
- 22,505
- Average volume (20 days)
- 34,748
- Beta (5 years)
- 1.29
- 52-week range
- $0.46 – $2.90
- RSI (14 days)
- 20.3
- Volatility (1 year)
- 155.7%
- Relative volume
- 0.25×
- WACC
- 11.5%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | AMST | S&P 500 | Difference | AMST per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -44.1% | -3.0% | −41.1 pts | ||
| 3 months | -55.6% | -2.8% | −52.8 pts | ||
| Year to date | -74.9% | +11.5% | −86.4 pts | ||
| 1 year | -82.7% | +13.5% | −96.1 pts | ||
| 3 years | -76.8% | +77.7% | −154.5 pts | -38.6% | +21.1% |
| 5 years | -97.2% | +72.6% | −169.8 pts | -51.1% | +11.5% |
Eight years at a glance
Fiscal years 2019 to 2026 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Amesite filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- News
- News
- News
- Update
- Update
About Amesite
Services-Prepackaged Software
Amesite Inc. is a technology company that develops and commercializes artificial intelligence solutions, primarily for the post-acute healthcare sector. Its offerings comprise two primary product lines: NurseMagic and LynkMagic, alongside its Amesite Engage platform. NurseMagic includes a business-to-business enterprise application and a direct-to-consumer application for individual nurses and caregivers, providing documentation assistance, workflow simplification, electronic medical record compatibility, and automated reporting. LynkMagic delivers enterprise artificial intelligence solutions tailored to healthcare and related organizations for workflow, compliance, and operational oversight. The company serves individual healthcare professionals as well as healthcare businesses, including skilled nursing facilities, home health agencies, hospice organizations, and assisted living communities.
Company profile, executives and historyAmesite stock: common questions
What is Amesite's stock price?
AMST closed at $0.47 on Nov 13, 2026, down 0.77% on the day. Over the past 52 weeks it traded between $0.46 and $2.90.
What is Amesite's market cap?
Amesite was worth $3.11M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is AMST's P/E ratio?
Amesite lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.60), so it has no meaningful P/E ratio.
How much revenue does Amesite make?
Amesite reported revenue of $340.70K for the twelve months to Sep 30, 2026, up 76.1% from a year earlier.
Does Amesite pay a dividend?
No. Amesite has not paid a cash dividend over the last twelve months.
How has AMST stock performed over the past year?
Including dividends, AMST returned -82.7% over the past year, against +13.5% for the S&P 500.
How many AMST shares are sold short?
0M shares were sold short at the latest FINRA report, 0.76% of the float, or 1.0 days of average trading volume.
Who are Amesite's competitors?
Companies most similar to Amesite by business, industry and size include NXNT, TPTI, BNAI, YAAS, FRSX.
See a number that looks wrong?